APOE and Alzheimer disease: The frequency of blood transfusion in the control group was higher than that in the case group (crude OR = 0.62). Stratified analysis by APOE‐e4 genotype showed no effect modification, that is, regardless of the APOE‐e4 status, a history of blood transfusion was not associated with an increased risk of AD.